Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
PDE4B as a microglia target to reduce neuroinflammation.
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Is metabolic flexibility altered in multiple sclerosis patients?
Gait and six-minute walk performance in persons with multiple sclerosis.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Multiple sclerosis in Syria.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
Vitamin D insufficiency and chronic diseases: Hype and reality.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.

Pages